Inhibition of MMP-2 activation and release as a novel mechanism for HDL-induced cardioprotection

FEBS Letters

Volumn 580, Issue 25, 2006, Pages 5974-5978

  Bellosta, Stefano ^a   Gomaraschi, Monica ^a   Canavesi, Monica ^a   Rossoni, Giuseppe ^a   Monetti, Mara ^a   Franceschini, Guido ^a   Calabresi, Laura ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Gelatinase A; High density lipoproteins; Ischemia reperfusion injury; Matrix metalloproteinases; Myocardial ischemia

Indexed keywords

GELATINASE A; HIGH DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DEATH; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME MECHANISM; ENZYME RELEASE; HEART DISEASE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HEART MUSCLE REPERFUSION; HEART PROTECTION; ISOLATED HEART; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; REPERFUSION INJURY;

ANIMALS; BASE SEQUENCE; DNA, COMPLEMENTARY; ENZYME ACTIVATION; HUMANS; LIPID PEROXIDES; LIPOPROTEINS, HDL; MATRIX METALLOPROTEINASE 2; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; RATS; REACTIVE OXYGEN SPECIES;

EID: 33750091672     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2006.10.006     Document Type: Article

References (21)

1. Visse R., and Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ. Res. 92 (2003) 827-839
2. Spinale F.G. Matrix metalloproteinases: regulation and dysregulation in the failing heart. Circ. Res. 90 (2002) 520-530
3. Matsumura S., Iwanaga S., Mochizuki S., Okamoto H., Ogawa S., and Okada Y. Targeted deletion or pharmacological inhibition of MMP-2 prevents cardiac rupture after myocardial infarction in mice. J. Clin. Invest. 115 (2005) 599-609
4. Wang W., Schulze C.J., Suarez-Pinzon W.L., Dyck J.R., Sawicki G., and Schulz R. Intracellular action of matrix metalloproteinase-2 accounts for acute myocardial ischemia and reperfusion injury. Circulation 106 (2002) 1543-1549
5. Cheung P.Y., Sawicki G., Wozniak M., Wang W., Radomski M.W., and Schulz R. Matrix metalloproteinase-2 contributes to ischemia-reperfusion injury in the heart. Circulation 101 (2000) 1833-1839
6. Calabresi L., Rossoni G., Gomaraschi M., Sisto F., Berti F., and Franceschini G. High-density lipoproteins protect isolated rat hearts from ischemia-reperfusion injury by reducing cardiac tumor necrosis factor-alpha content and enhancing prostaglandin release. Circ. Res. 92 (2003) 330-337
7. Rossoni G., Gomaraschi M., Berti F., Sirtori C.R., Franceschini G., and Calabresi L. Synthetic high-density lipoproteins exert cardioprotective effects in myocardial ischemia/reperfusion injury. J. Pharmacol. Exp. Ther. 308 (2004) 79-84
8. Robbesyn F., Auge N., Vindis C., Cantero A.V., Barbaras R., Negre-Salvayre A., and Salvayre R. High-density lipoproteins prevent the oxidized low-density lipoprotein-induced endothelial growth factor receptor activation and subsequent matrix metalloproteinase-2 upregulation. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 1206-1212
9. Xu X.P., Meisel S.R., Ong J.M., Kaul S., Cercek B., Rajavashisth T.B., Sharifi B., and Shah P.K. Oxidized low-density lipoprotein regulates matrix metalloproteinase-9 and its tissue inhibitor in human monocyte-derived macrophages. Circulation 99 (1999) 993-998
10. Nicholls S.J., Cutri B., Worthley S.G., Kee P., Rye K.A., Bao S., and Barter P.J. Impact of short-term administration of high-density lipoproteins and atorvastatin on atherosclerosis in rabbits. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 2416-2421
11. Bellosta S., Via D., Canavesi M., Pfister P., Fumagalli R., Paoletti R., and Bernini F. HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages. Arterioscler. Thromb. Vasc. Biol. 18 (1998) 1671-1678
12. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
13. Galis Z.S., and Khatri J.J. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ. Res. 90 (2002) 251-262
14. Carden D.L., and Granger D.N. Pathophysiology of ischaemia-reperfusion injury. J. Pathol. 190 (2000) 255-266
15. Wang W., Sawicki G., and Schulz R. Peroxynitrite-induced myocardial injury is mediated through matrix metalloproteinase-2. Cardiovasc. Res. 53 (2002) 165-174
16. Lalu M.M., Pasini E., Schulze C.J., Ferrari-Vivaldi M., Ferrari-Vivaldi G., Bachetti T., and Schulz R. Ischaemia-reperfusion injury activates matrix metalloproteinases in the human heart. Eur. Heart J. 26 (2005) 27-35
17. Chander R., and Kapoor N.K. High density lipoprotein is a scavenger of superoxide anions. Biochem. Pharmacol. 40 (1990) 1663-1665
18. Nicholls S.J., Dusting G.J., Cutri B., Bao S., Drummond G.R., Rye K.A., and Barter P.J. Reconstituted high-density lipoproteins inhibit the acute pro-oxidant and proinflammatory vascular changes induced by a periarterial collar in normocholesterolemic rabbits. Circulation 111 (2005) 1543-1550
19. Marchesi M., Booth E.A., Davis T., Bisgaier C.L., and Lucchesi B.R. Apolipoprotein A-IMilano and 1-palmitoyl-2-oleoyl phosphatidylcholine complex (ETC-216) protects the in vivo rabbit heart from regional ischemia-reperfusion injury. J. Pharmacol. Exp. Ther. 311 (2004) 1023-1031
20. Kunitake S.T., Jarvis M.R., Hamilton R.L., and Kane J.P. Binding of transition metals by apolipoprotein A-I-containing plasma lipoproteins: inhibition of oxidation of low density lipoproteins. Proc. Natl. Acad. Sci. USA 89 (1992) 6993-6997
21. Aviram M., Rosenblat M., Bisgaier C.L., Newton R.S., Primo-Parmo S.L., and La Du B.N. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. J. Clin. Invest. 101 (1998) 1581-1590